PDF(Pubmed)
Abstract：
UNASSIGNED: Even though innumerable quality of life (QOL) questionnaires have been developed in palliative care, there is no gold standard assessment tool for QOL and no single questionnaire that fits all purposes and individuals. An important challenge to QOL assessments in palliative care is the highly diverse patient population with different diagnoses, disease states/prognosis, and languages. In an outpatient palliative care clinic population, FACIT-Pal-14 proved to be a valid and reliable scale in palliative care patients.
UNASSIGNED: We aimed to (i) determine the psychometric properties of the Tagalog version of the Functional Assessment of Chronic Illness Therapy - Palliative Care - 14 (FACIT-Pal-14) and (ii) measure the Quality of Life (QOL) of Filipino cancer patients.
UNASSIGNED: This was a cross-sectional study. License for the use of the Tagalog version 4 of the FACIT-Pal-14 was requested from FACIT.org. To know the psychometric properties of the scales, Cronbach\'s alpha coefficient was used to assess reliability, and exploratory factor analysis, Pearson correlations, and independent samples T-test were used to determine validity.
UNASSIGNED: The Tagalog FACIT-Pal-14 was administered to 500 Filipino cancer patients consulting at the outpatient department of a training and regional medical center. The participants were mostly female (65.5%), aged 64 years and younger (82.6%), and had breast cancer (53.2%), colorectal cancer (19.2%), and lung cancer (9.4%). The mean Tagalog FACIT-Pal-14 score was 47.35 out of 56 (SD=7.14). The Cronbach\'s alpha coefficient of the Tagalog version of FACIT-Pal-14 was 0.784. Significantly lower mean Tagalog FACIT-Pal-14 scores were found in patients with Karnofsky Performance Status (KPS) 70 and lower, and Eastern Cooperative Oncology Group Performance Status (ECOG-PS) 2 and above compared with patients with KPS 80 and higher and ECOG-PS 0-1. (t=3.439, p<.001). While the Tagalog FACIT-Pal-14 scores, KPS, and ECOG scores only revealed a very weak, positive correlation (r=0.095; p <0.05), this ability to distinguish between groups known to differ regarding performance status showed the construct validity of the Tagalog FACIT-Pal-14.
UNASSIGNED: In an outpatient oncology clinic population, the FACIT-Pal 14 showed evidence of reliability and construct validity for evaluating palliative care-specific QOL in Filipino cancer patients. Using this measure, Filipino cancer patients have a good QOL. Therefore, it is recommended that the Tagalog FACIT-Pal-14 be used on subsequent patient follow-ups to assess how their QOL would change over time so that the palliative care services provided will be suited to their needs.
UNASSIGNED: We aimed to (i) determine the psychometric properties of the Tagalog version of the Functional Assessment of Chronic Illness Therapy - Palliative Care - 14 (FACIT-Pal-14) and (ii) measure the Quality of Life (QOL) of Filipino cancer patients.
UNASSIGNED: This was a cross-sectional study. License for the use of the Tagalog version 4 of the FACIT-Pal-14 was requested from FACIT.org. To know the psychometric properties of the scales, Cronbach\'s alpha coefficient was used to assess reliability, and exploratory factor analysis, Pearson correlations, and independent samples T-test were used to determine validity.
UNASSIGNED: The Tagalog FACIT-Pal-14 was administered to 500 Filipino cancer patients consulting at the outpatient department of a training and regional medical center. The participants were mostly female (65.5%), aged 64 years and younger (82.6%), and had breast cancer (53.2%), colorectal cancer (19.2%), and lung cancer (9.4%). The mean Tagalog FACIT-Pal-14 score was 47.35 out of 56 (SD=7.14). The Cronbach\'s alpha coefficient of the Tagalog version of FACIT-Pal-14 was 0.784. Significantly lower mean Tagalog FACIT-Pal-14 scores were found in patients with Karnofsky Performance Status (KPS) 70 and lower, and Eastern Cooperative Oncology Group Performance Status (ECOG-PS) 2 and above compared with patients with KPS 80 and higher and ECOG-PS 0-1. (t=3.439, p<.001). While the Tagalog FACIT-Pal-14 scores, KPS, and ECOG scores only revealed a very weak, positive correlation (r=0.095; p <0.05), this ability to distinguish between groups known to differ regarding performance status showed the construct validity of the Tagalog FACIT-Pal-14.
UNASSIGNED: In an outpatient oncology clinic population, the FACIT-Pal 14 showed evidence of reliability and construct validity for evaluating palliative care-specific QOL in Filipino cancer patients. Using this measure, Filipino cancer patients have a good QOL. Therefore, it is recommended that the Tagalog FACIT-Pal-14 be used on subsequent patient follow-ups to assess how their QOL would change over time so that the palliative care services provided will be suited to their needs.
摘要：
■即使在姑息治疗中已经开发了无数的生活质量（QOL）问卷，没有黄金标准的QOL评估工具，也没有适合所有目的和个人的单一问卷。姑息治疗中QOL评估的一个重要挑战是高度多样化的患者群体，具有不同的诊断，疾病状态/预后，和语言。在门诊姑息治疗诊所人群中，FACIT-Pal14被证明是姑息治疗患者的有效且可靠的量表。
■我们的目的是（i）确定他加禄语版本的慢性病治疗功能评估-姑息治疗-14（FACIT-帕尔-14）的心理测量特性，以及（ii）测量菲律宾癌症患者的生活质量（QOL）。
■这是一项横断面研究。从FACIT.org请求使用FACIT-Pal14的Tagalog版本4的许可证。要知道量表的心理测量特性，Cronbach的α系数用于评估可靠性，和探索性因素分析，皮尔逊相关性，和独立样本T检验用于确定有效性。
■在培训和地区医疗中心的门诊部咨询的500名菲律宾癌症患者服用了他加禄语FACIT-Pal14。参与者主要是女性（65.5％），64岁及以下(82.6%)，患有乳腺癌（53.2%），结直肠癌（19.2%），和肺癌(9.4%)。TagalogFACIT-Pal-14的平均评分为56分的47.35分(SD=7.14)。他加禄版FACIT-Pal14的Cronbach'sα系数为0.784。在Karnofsky表现状态（KPS）70和更低的患者中发现了显著较低的平均TagalogFACIT-Pal14评分，与KPS80及更高和ECOG-PS0-1的患者相比，东部肿瘤协作组表现状况（ECOG-PS）2及以上。（t=3.439，p<.001）。虽然他加禄语FACIT-PAL-14得分，KPS,而ECOG分数只显示出一个非常弱的，正相关(r=0.095；p<0.05)，这种区分已知在表现状态方面存在差异的组的能力显示了他加禄语FACIT-Pal-14的构建效度.
■在门诊肿瘤诊所人群中，FACIT-Pal14在评估菲律宾癌症患者姑息治疗特异性QOL方面显示了可靠性和结构效度的证据.使用此措施，菲律宾癌症患者有良好的生活质量。因此,建议在随后的患者随访中使用TagalogFACIT-Pal-14,以评估其QOL随时间的变化情况,从而使所提供的姑息治疗服务适合其需要.
■我们的目的是（i）确定他加禄语版本的慢性病治疗功能评估-姑息治疗-14（FACIT-帕尔-14）的心理测量特性，以及（ii）测量菲律宾癌症患者的生活质量（QOL）。
■这是一项横断面研究。从FACIT.org请求使用FACIT-Pal14的Tagalog版本4的许可证。要知道量表的心理测量特性，Cronbach的α系数用于评估可靠性，和探索性因素分析，皮尔逊相关性，和独立样本T检验用于确定有效性。
■在培训和地区医疗中心的门诊部咨询的500名菲律宾癌症患者服用了他加禄语FACIT-Pal14。参与者主要是女性（65.5％），64岁及以下(82.6%)，患有乳腺癌（53.2%），结直肠癌（19.2%），和肺癌(9.4%)。TagalogFACIT-Pal-14的平均评分为56分的47.35分(SD=7.14)。他加禄版FACIT-Pal14的Cronbach'sα系数为0.784。在Karnofsky表现状态（KPS）70和更低的患者中发现了显著较低的平均TagalogFACIT-Pal14评分，与KPS80及更高和ECOG-PS0-1的患者相比，东部肿瘤协作组表现状况（ECOG-PS）2及以上。（t=3.439，p<.001）。虽然他加禄语FACIT-PAL-14得分，KPS,而ECOG分数只显示出一个非常弱的，正相关(r=0.095；p<0.05)，这种区分已知在表现状态方面存在差异的组的能力显示了他加禄语FACIT-Pal-14的构建效度.
■在门诊肿瘤诊所人群中，FACIT-Pal14在评估菲律宾癌症患者姑息治疗特异性QOL方面显示了可靠性和结构效度的证据.使用此措施，菲律宾癌症患者有良好的生活质量。因此,建议在随后的患者随访中使用TagalogFACIT-Pal-14,以评估其QOL随时间的变化情况,从而使所提供的姑息治疗服务适合其需要.
